TY - JOUR
T1 - Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men
AU - Gibney, J
AU - Wolthers, T
AU - Johannsson, G
AU - Umpleby, A M
AU - Ho, K K Y
PY - 2005/8
Y1 - 2005/8
N2 - We investigated the impact of growth hormone (GH) alone, testosterone ( T) alone, and combined GH and T on whole body protein metabolism. Twelve hypopituitary men participated in two studies. Study 1 compared the effects of GH alone with GH plus T, and study 2 compared the effects of T alone with GH plus T. IGF-I, resting energy expenditure (REE), and fat oxidation (F-ox) and rates of whole body leucine appearance (R-a), oxidation (L-ox), and nonoxidative leucine disposal (NOLD) were measured. In study 1, GH treatment increased mean plasma IGF-I (P <0.001). GH did not change leucine R-a but reduced L-ox (P <0.02) and increased NOLD (P <0.02). Addition of T resulted in an additional increase in IGF-I (P <0.05), reduction in Lox (P <0.002), and increase in NOLD (P <0.002). In study 2, T alone did not alter IGF- I levels. T alone did not change leucine Ra but reduced L-ox (P <0.01) and increased NOLD (P <0.01). Addition of GH further reduced L-ox (P <0.05) and increased NOLD (P <0.05). In both studies, combined treatments on REE and F-ox were greater than either alone. In summary, GH-induced increase of circulating IGF-I is augmented by T, which does not increase IGF-I in the absence of GH. T and GH exerted independent and additive effects on protein metabolism, F-ox and REE. The anabolic effects of T are independent of circulating IGF-I
AB - We investigated the impact of growth hormone (GH) alone, testosterone ( T) alone, and combined GH and T on whole body protein metabolism. Twelve hypopituitary men participated in two studies. Study 1 compared the effects of GH alone with GH plus T, and study 2 compared the effects of T alone with GH plus T. IGF-I, resting energy expenditure (REE), and fat oxidation (F-ox) and rates of whole body leucine appearance (R-a), oxidation (L-ox), and nonoxidative leucine disposal (NOLD) were measured. In study 1, GH treatment increased mean plasma IGF-I (P <0.001). GH did not change leucine R-a but reduced L-ox (P <0.02) and increased NOLD (P <0.02). Addition of T resulted in an additional increase in IGF-I (P <0.05), reduction in Lox (P <0.002), and increase in NOLD (P <0.002). In study 2, T alone did not alter IGF- I levels. T alone did not change leucine Ra but reduced L-ox (P <0.01) and increased NOLD (P <0.01). Addition of GH further reduced L-ox (P <0.05) and increased NOLD (P <0.05). In both studies, combined treatments on REE and F-ox were greater than either alone. In summary, GH-induced increase of circulating IGF-I is augmented by T, which does not increase IGF-I in the absence of GH. T and GH exerted independent and additive effects on protein metabolism, F-ox and REE. The anabolic effects of T are independent of circulating IGF-I
U2 - 10.1152/ajpendo.00483.2004
DO - 10.1152/ajpendo.00483.2004
M3 - Article
VL - 289
SP - E266 - E271
JO - AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM
JF - AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM
IS - 2
ER -